期刊文献+

晚期胰腺癌患者凝血、抗凝功能的变化及意义 被引量:1

Change and Significance of Coagulantion and Anticoagulantion Systems of Patients with Late Pancreas Carcinoma
下载PDF
导出
摘要 检测 2 2例晚期胰腺癌患者的凝血酶原时间 (PT)、激活的部分凝血酶原时间 (APTT)、纤维蛋白原 (Fg)、ville brand因子 (VWF)等凝血指标及抗凝血酶 活性 (AT- A)、抗凝血酶 抗原 (AT- Ag)、C蛋白活性 (PC∶ A)等抗凝指标 ,并与正常人进行对比分析。结果显示 ,晚期胰腺癌患者的 PT、APTT明显延长 (P<0 .0 1) ,Fg、VWF升高 (P<0 .0 1) ,AT- A%降低 (P<0 .0 1) ,AT- Ag,PC∶ A升高 (P<0 .0 1)。提示晚期胰腺癌患者存在明显的凝血。 The plasma coagulantion indexes include prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(Fg),ville brand factor(VWF)and anticoagulantion indexies include antithrombin Ⅲ activity(AT ⅢA),antithrombin Ⅲ antigen(AT ⅢAg),protein c activity(PC∶A)of patiens with late pancreas carcinoma were analysed and were compared with normal people The result showed that the PT,APTT,Fg,VWF were all higher than normal(P<0 01) AT ⅢA% was lower than normal(P<0 01),but AT ⅢAg,PC∶A were all higher than normal(P<0 01) This suggests that the plasma coagulantion and anticoagulantion systems are obvious abnormal in the patients with late pancreas carcinoma
出处 《山东医药》 CAS 北大核心 2000年第7期19-20,共2页 Shandong Medical Journal
关键词 胰腺癌 凝血指标 抗凝血指标 Carcinoma of pancreas Coagulantion index Anticoagulantion index
  • 相关文献

参考文献4

二级参考文献6

  • 1韩锐,肿瘤化学预防及药物治疗,1991年
  • 2李振,恶性肿瘤的化学治疗与免疫治疗,1990年
  • 3叶应妩,临床实验诊断学.上,1989年
  • 4王振义,中华血液学杂志,1981年,2卷,105页
  • 5张凤春,白求恩医科大学学报,1995年,11卷,6期,101页
  • 6吴国新,李建勇.血小板表面及血浆内α—颗粒膜蛋白的放射免疫测量[J].中华血液学杂志,1992,13(2):99-100. 被引量:104

共引文献31

同被引文献17

  • 1张璐芳,赵军.妇科肿瘤合并急性下肢深静脉血栓形成14例临床分析[J].实用妇产科杂志,2005,21(3):162-165. 被引量:24
  • 2范桂高.原发性深静脉血栓形成或肺栓塞后癌肿诊断的风险[J].国外医学.心血管疾病分册.1999(02)
  • 3徐秋霞等主编.血栓栓塞性疾病[M]. 中国医药科技出版社, 2004
  • 4王辰主编.肺栓塞[M]. 人民卫生出版社, 2003
  • 5Tallman MS,Kwaan HC.Reassessing the hemostatic disorder associated with acute promyelocytic leukemia[].Blood.1992
  • 6Edwards RL,Rickles FR.Thrombosis and cancer[].Disorders of thrombosis.1996
  • 7Lee AY,Levine MN.Management of venous thromboembolism in cancer patients[].Oncology.2000
  • 8Weltermann A,Pabinger I,Geissler K,et al.Hypofibrinogenemia in nonM3 acute myeloid leukemia, incidence, clinical and laboratory characteristics and prognosis[].Leukemia.1998
  • 9Zurborn KH,Gram J,Glander K,et al.Influence of cytostatic traetment on the coagulation system and fibrinolysis in patiens with non-Hodgkin s lymphomas and acuteleukemias[].European Journal of Haematology.1991
  • 10Levine MN.Management of venous thrombosis in cancer.Recent developments in diagnosis, prevention and therapy[].TUMORI.2001

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部